Dr. Michael Hyder, MD
Claim this profileUMass Chan Medical School
Studies Atrial Fibrillation
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
Clinical Trials Michael Hyder, MD is currently running
More about Michael Hyder, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Michael Hyder, MD has experience with
- AFSW Guided DOAC
- Continuous DOAC Therapy
Breakdown of trials Michael Hyder, MD has run
Atrial Fibrillation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Hyder, MD specialize in?
Michael Hyder, MD focuses on Atrial Fibrillation and other conditions. In particular, much of their work with Atrial Fibrillation has involved treating patients, or patients who are undergoing treatment.
Is Michael Hyder, MD currently recruiting for clinical trials?
Yes, Michael Hyder, MD is currently recruiting for 1 clinical trial in Worcester Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Michael Hyder, MD has studied deeply?
Yes, Michael Hyder, MD has studied treatments such as AFSW Guided DOAC, Continuous DOAC therapy.
What is the best way to schedule an appointment with Michael Hyder, MD?
Apply for one of the trials that Michael Hyder, MD is conducting.
What is the office address of Michael Hyder, MD?
The office of Michael Hyder, MD is located at: UMass Chan Medical School, Worcester, Massachusetts 01655 United States. This is the address for their practice at the UMass Chan Medical School.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.